Suppr超能文献

自闭症特质对 ADHD 儿童药物治疗的反应和副作用的影响:来自前瞻性临床队列的结果。

The effect of autistic traits on response to and side-effects of pharmacological ADHD treatment in children with ADHD: results from a prospective clinical cohort.

机构信息

Department of Clinical Sciences, Child and Adolescent Psychiatry, Umea University, Universitetstorget 4, SE907 36, Umea, Sweden.

Child and Adolescent Psychiatric Clinic, Stockholm, Sweden.

出版信息

J Neurodev Disord. 2022 Mar 6;14(1):17. doi: 10.1186/s11689-022-09424-2.

Abstract

BACKGROUND

Attention deficit hyperactivity disorder (ADHD) is a common childhood behavioral condition that globally affects an average of around 5% of children and is associated with several adverse life outcomes. Comorbidity with autism spectrum disorder (ASD) is highly prevalent. Pharmacological treatment for ADHD symptoms has been shown to be effective. However, the prevailing perception is that children with ADHD and concomitant ASD symptoms report poorer efficacy and more side effects. This has been supported by studies on this population, but prospective studies directly comparing children with ADHD and different levels of ASD symptoms are lacking. We aimed to assess if children with ADHD and concomitant ASD symptoms differ regarding effects and side-effects of pharmacological ADHD treatment compared to children with ADHD without ASD traits. This is to our knowledge the second study to directly compare the effect of ADHD medication between ADHD patients with different levels of ASD symptoms.

METHODS

In a non-randomized, observational, prospective cohort study, 323 patients aged 6 to 17 years who were diagnosed with ADHD and starting pharmacological treatment were divided into two groups: one with high level of ASD symptoms (ASD group, N=71) and one with low level of ASD symptoms (non-ASD group, N = 252). Treatment outcome was measured as ADHD symptoms, and evaluated using the Swanson, Nolan and Pelham Teacher and Parent ADHD rating scale-version IV (SNAP-IV). Side-effects were evaluated using the Pediatric Side Effects Checklist (P-SEC), at 3 months follow-up.

RESULTS

From baseline to 3 months, there was no significant difference in neither treatment effect nor number of clinically significant adverse events experienced between the ASD group and the non-ASD group.

CONCLUSIONS

Our results did not implicate that ADHD patients with concomitant ASD symptoms have decreased treatment effect of ADHD medication than patients with ADHD without concomitant ASD symptoms. Neither did the results support that ADHD patients with ASD symptoms experienced significantly more side-effects than ADHD patients without ASD symptoms. Although, we did not analyze different medications separately, this is in line with the only previous study directly comparing methylphenidate treatment in children with or without ASD.

TRIAL REGISTRATION

NCT02136147 , May 12, 2014.

摘要

背景

注意力缺陷多动障碍(ADHD)是一种常见的儿童行为障碍,全球平均影响约 5%的儿童,与多种不良生活结局有关。共病自闭症谱系障碍(ASD)的患病率很高。药物治疗 ADHD 症状已被证明是有效的。然而,普遍的看法是,伴有 ASD 症状的 ADHD 儿童报告疗效较差且副作用更多。这一点得到了对该人群进行的研究的支持,但缺乏直接比较 ADHD 儿童和不同 ASD 症状水平的前瞻性研究。我们旨在评估伴有 ASD 症状的 ADHD 儿童与不伴有 ASD 特征的 ADHD 儿童相比,药物治疗 ADHD 症状的疗效和副作用是否存在差异。这是我们所知的第二项直接比较 ADHD 患者不同 ASD 症状水平下 ADHD 药物治疗效果的研究。

方法

在一项非随机、观察性、前瞻性队列研究中,将 323 名年龄在 6 至 17 岁之间被诊断为 ADHD 并开始药物治疗的患者分为两组:一组有高水平的 ASD 症状(ASD 组,N=71),另一组有低水平的 ASD 症状(非 ASD 组,N=252)。使用 Swanson、Nolan 和 Pelham 教师和家长 ADHD 评定量表第四版(SNAP-IV)评估治疗效果。使用儿科副作用检查表(P-SEC)在 3 个月随访时评估副作用。

结果

从基线到 3 个月,ASD 组和非 ASD 组在治疗效果或经历的临床显著不良事件数量方面均无显著差异。

结论

我们的结果并未表明伴有 ASD 症状的 ADHD 患者的 ADHD 药物治疗效果低于不伴有 ASD 症状的 ADHD 患者。也没有结果支持 ASD 症状的 ADHD 患者比不伴有 ASD 症状的 ADHD 患者经历更多的副作用。尽管我们没有分别分析不同的药物,但这与唯一一项直接比较儿童中使用哌甲酯治疗伴或不伴 ASD 的研究结果一致。

试验注册

NCT02136147,2014 年 5 月 12 日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb51/8903657/b85d670900af/11689_2022_9424_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验